SPOTLIGHT

"Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy


Team Members
  • Dr. David Gladstone - Sunnybrook Health Sciences Centre, University of Toronto

Spotlight is a randomized controlled trial that will compare the effects of rFVIIa vs. placebo on attenuating ICH growth, and explore variables that modify treatment response.